Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1320
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02406521 | Exploratory Study of Radium-223 and VEGF-Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma and Bone Mets | ||
| NCT02425904 | Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis and LCH-related Disorders | ||
| NCT00140504 | Preventing Adverse Drug Events With PatientSite | ||
| NCT00766467 | A Randomized Placebo-Controlled Trial of Armodafinil (Nuvigil) for Fatigue in Patients With Malignant Gliomas | ||
| NCT03022032 | The HOPE Trial and the SMART Study | ||
| NCT03408314 | The PediQUEST Response Intervention Study | ||
| NCT03654716 | Phase 1 Study of the Dual MDM2/MDMX Inhibitor ALRN-6924 in Pediatric Cancer | ||
| NCT00182052 | Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer | ||
| NCT02285439 | Study of MEK162 for Children With Low-Grade Gliomas | ||
| NCT06543511 | MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies | ||
| NCT01740219 | Promoting Organizational Capacity to Implement Cancer Control Programs Among Latino Churches | ||
| NCT06950307 | Hypofractionation for Prostate Cancer in Africa: A Feasibility Study | ||
| NCT07439211 | Assessing PI3K Gamma Inhibition With Azacitidine, Venetoclax and Eganelisib in Patients With Acute Myeloid Leukemia | ||
| NCT00361309 | SU011248 in Advanced Hepatocellular Carcinoma | ||
| NCT02176031 | Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD | ||
| NCT05403801 | STAMP+CBT mHealth for Cancer Pain | ||
| NCT05210101 | A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals | ||
| NCT02423148 | Pilot Study of Novel Fluorescence Endoscopic Device for Sentinel Lymph Node Mapping in Lung Cancer | ||
| NCT00148707 | Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer | ||
| NCT04434040 | Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA) | ||
| NCT06907797 | Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing | ||
| NCT01105988 | Evaluating Tumor Pseudoprogression With FLT-PET and MRI | ||
| NCT06153797 | A Positive Psychology Based Intervention (PATH-C) for Caregivers of HSCT Survivors | ||
| NCT00441142 | Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors | ||
| NCT06038318 | Promoting Resilience in Early Survivorship Among Adolescents and Young Adults With Cancer | ||
| NCT05796570 | A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies | ||
| NCT00366457 | Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer | ||
| NCT00681694 | Long-Term Outcomes of Alternative Brachytherapy Techniques for Early Prostate Cancer | ||
| NCT00590902 | Ph II OSI-774 (Erlotinib,Tarceva) In Advanced Bronchioloalveolar Cell Lung Cancer | ||
| NCT05800366 | A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma | ||
| NCT04356729 | A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma | ||
| NCT03325985 | Emergency Medicine Palliative Care Access | ||
| NCT06523868 | Evaluation of Multi-Cancer Early Detection Testing in a High-Risk Military Population: The Sentinel Study | ||
| NCT03762590 | GENetic Education Risk Assessment and TEsting Study | ||
| NCT02326974 | T-DM1+Pertuzumab in Pre-OP Early-Stage HER2+ BRCA | ||
| NCT01858688 | A Phase II, Prospective Study of MRI in the Reclassification of Men Considering Active Surveillance in Prostate Cancer | ||
| NCT04789486 | Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer | ||
| NCT00134641 | Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas | ||
| NCT00852462 | Lung Cancer Symptom Assessment and Management Intervention | ||
| NCT04717050 | Reducing Metabolic Dysregulation in Obese Latina Breast Cancer Survivors Using Physical Activity | ||
| NCT04468061 | Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC | ||
| NCT00355407 | Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation | ||
| NCT03936465 | Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer | ||
| NCT03075527 | A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma | ||
| NCT02514824 | MLN0128 in Recurrent/Metastatic Merkel Cell Carcinoma | ||
| NCT00458237 | Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer | ||
| NCT02041429 | Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory Brca | ||
| NCT03835819 | A Phase 2 Study of Mirvetuximab Soravtansine (IMGN853) and Pembrolizumab in Endometrial Cancer (EC) | ||
| NCT01465334 | Ofatumumab With High Dose Methylprednisone Followed by Ofatumumab and Alemtuzumab in 17p CLL | ||
| NCT03417739 | A Phase II Study of BVD-523 in Metastatic Uveal Melanoma |
